Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an investigational nutritional supplement combination consisting of iron sulphate (providing 12.5 mg of elemental iron) and folic acid (50 μg). It was evaluated by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as part of the Nepal Nutrition Intervention Project-Sarlahi (NNIPS-4), a Phase 3 community-based, cluster-randomized trial (NCT00109551). The study aimed to assess the impact of daily supplementation on mortality and morbidity in children aged 1-35 months in rural Nepal. Formulated as dispersible tablets by Nutriset, the intervention was designed to address iron and folate deficiencies common in young children in low-resource settings. However, the iron-folic acid arm of the trial was terminated early in November 2003 following a recommendation from the Data Safety and Monitoring Board, as the supplement did not demonstrate a significant reduction in all-cause mortality compared to placebo.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iron sulphate + folic acid.